Washington: An inexpensive drug in clinical use for 40 years as an antifungal can `starve` tumours, slow down their growth and has the potential to be an important chemotherapeutic tool, a new study has claimed. Researchers from the University of Texas at Austin found that thiabendazole, an FDA-approved, generic drug destroys newly established blood vessels, making it a vascular disrupting agent. Inhibiting blood vessel, or vascular, growth can be an important chemotherapeutic tool because it starves tumours. Tumours induce new blood vessel formation to feed their out-of-control growth.
Firing across Pak-India border kills two
Communal violence on rise in BJP rule: Mayawati
CCTV captures chain snatcher at Wadala station
SC refuses to postpone UPSC preliminary examination